Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02381886
Recruitment Status : Active, not recruiting
First Posted : March 6, 2015
Last Update Posted : December 10, 2021
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : December 7, 2016
Estimated Study Completion Date : October 25, 2024